The impact of antibiotic management on resistance

被引:5
作者
Bosso, JA [1 ]
机构
[1] Med Univ S Carolina, Coll Pharm, Dept Pharm & Clin Sci, Charleston, SC 29425 USA
来源
PHARMACOTHERAPY | 2004年 / 24卷 / 12期
关键词
antibiotic management; resistance; formulary substitution; formulary restriction; antibiotic restriction;
D O I
10.1592/phco.24.18.224S.52233
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The misguided presumption that a simple inverse relationship exists between the use of antibiotics and the emergence of bacterial resistance (i.e., increasing antibiotic use equals decreasing susceptibility and vice versa) has handicapped a full understanding of this relationship and perhaps efforts to bring resistance under control. In fact, this relationship is complicated. This article reviews factors that obscure detection of associations between antibiotic use and the emergence of resistance. It also provides a sample of the extensive data on this subject in the hope of encouraging the conduct of more sophisticated studies of the relationship between antibiotic use and the emergence of resistance. Such studies are necessary to provide institutions with the data they need to make informed decisions regarding antibiotic use.
引用
收藏
页码:224S / 231S
页数:8
相关论文
共 19 条
[11]   Consumption of imipenem correlates with β-lactam resistance in Pseudomonas aeruginosa [J].
Lepper, PM ;
Grusa, E ;
Reichl, H ;
Högel, J ;
Trautmann, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) :2920-2925
[12]   Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients [J].
Mebis, J ;
Goossens, H ;
Bruyneel, P ;
Sion, JP ;
Meeus, I ;
Van Droogenbroeck, J ;
Schroyens, W ;
Berneman, ZN .
LEUKEMIA, 1998, 12 (10) :1627-1629
[13]   Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001) [J].
Mutnick, AH ;
Rhomberg, PR ;
Sader, HS ;
Jones, RN .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (02) :290-296
[14]   Antibiotic resistance among gram-negative bacilli in US intensive care units - Implications for fluoroquinolone use [J].
Neuhauser, MM ;
Weinstein, RA ;
Rydman, R ;
Danziger, LH ;
Karam, G ;
Quinn, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (07) :885-888
[15]   Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci [J].
Quale, J ;
Landman, D ;
Saurina, G ;
Atwood, E ;
DiTore, V ;
Patel, K .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (05) :1020-1025
[16]   Glass restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella [J].
Rahal, JJ ;
Urban, C ;
Horn, D ;
Freeman, K ;
Segal-Maurer, S ;
Maurer, J ;
Mariano, N ;
Marks, S ;
Burns, JM ;
Dominick, D ;
Lim, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (14) :1233-1237
[17]   The effect of an antimicrobial restriction program on Pseudomonas aeruginosa resistance to β-lactams in a large teaching hospital [J].
Regal, RE ;
DePestel, DD ;
VandenBussche, HL .
PHARMACOTHERAPY, 2003, 23 (05) :618-624
[18]  
Smith Keith., 2000, ENTERPRISE INNOVATIO, V1, P73, DOI [DOI 10.1080/146324400363536, 10.1080/146324400363536]
[19]   Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000 [J].
Zervos, MJ ;
Hershberger, E ;
Nicolau, DP ;
Ritchie, DJ ;
Blackner, LK ;
Coyle, EA ;
Donnelly, AJ ;
Eckel, SF ;
Eng, RHK ;
Hiltz, A ;
Kuyumjian, AG ;
Krebs, W ;
McDaniel, A ;
Hogan, P ;
Lubowski, TJ .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (12) :1643-1648